SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations andTP53Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome
2022 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations andTP53Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome
Hasselblatt, M.; Thomas, C.; Federico, A.; Nemes, K.; Johann, P. D.; Bison, B. & Bens, S. et al. (2022)
American Journal of Surgical Pathology,. DOI: https://doi.org/10.1097/PAS.0000000000001905
